Cleared Traditional

K212883 - ers2 - ergoline Rehabilitation System (FDA 510(k) Clearance)

Jul 2022
Decision
308d
Days
Class 2
Risk

K212883 is an FDA 510(k) clearance for the ers2 - ergoline Rehabilitation System. This device is classified as a Transmitters And Receivers, Physiological Signal, Radiofrequency (Class II - Special Controls, product code DRG).

Submitted by Ergoline GmbH (Bitz, DE). The FDA issued a Cleared decision on July 15, 2022, 308 days after receiving the submission on September 10, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2910.

Submission Details

510(k) Number K212883 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2021
Decision Date July 15, 2022
Days to Decision 308 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRG - Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2910